1,3-dipropyl-8-cyclopentylxanthine has been researched along with Disease Exacerbation in 2 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cognato, GP | 1 |
| Agostinho, PM | 1 |
| Hockemeyer, J | 1 |
| Müller, CE | 1 |
| Souza, DO | 1 |
| Cunha, RA | 1 |
| Gouder, N | 1 |
| Scheurer, L | 1 |
| Fritschy, JM | 1 |
| Boison, D | 1 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Disease Exacerbation
| Article | Year |
|---|---|
Caffeine and an adenosine A(2A) receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life.
Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Animals, Newborn; Caffeine; Diseas | 2010 |
Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis.
Topics: Action Potentials; Adenosine A1 Receptor Antagonists; Adenosine Kinase; Animals; Anticonvulsants; As | 2004 |